​

2seventy bio (TSVT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

TSVT Stock Forecast

2seventy bio (TSVT) stock forecast, based on 9 Wall Street analysts, predicts a 12-month average price target of $5.00, with a high of $5.00 and a low of $5.00. This represents a 0.40% increase from the last price of $4.98.

High: $5 Avg: $5 Low: $5 Last Closed Price: $4.98

TSVT Stock Rating

2seventy bio stock's rating consensus is Hold, based on 9 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (44.44%), 5 Hold (55.56%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 9 0 5 4 Strong Sell Sell Hold Buy Strong Buy

TSVT Price Target Upside V Benchmarks

TypeNameUpside
Stock2seventy bio0.40%
SectorHealthcare Stocks 35.25%
IndustryBiotech Stocks 86.56%

Price Target Trends

1M3M12M
# Anlaysts-12
Avg Price Target-$5.00$3.50
Last Closing Price$4.98$4.98$4.98
Upside/Downside-0.40%-29.72%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25--3--3
Mar, 25-12-14
Feb, 25-22-15
Jan, 25-22-15
Dec, 24-22-15
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 14, 2025Morgan Stanley$5.00$4.951.01%0.40%
Jun 06, 2024Salveen RichterGoldman Sachs$2.00$4.56-56.14%-59.84%
May 02, 2022Goldman Sachs$26.00$13.4693.16%422.09%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 12, 2024Goldman SachsSellSellhold
Jun 06, 2024Goldman SachsBuySelldowngrade
Apr 07, 2024CitigroupBuyBuyhold
Jan 31, 2024Leerink PartnersOutperformupgrade
Sep 13, 2023GuggenheimNeutraldowngrade
Mar 17, 2023WedbushOutperformOutperformhold
Jan 10, 2023SVB LeerinkOutperformOutperformhold
May 02, 2022Goldman SachsBuyinitialise
Apr 26, 2022Zacks Investment ResearchBuyupgrade

Financial Forecast

EPS Forecast

$-10 $-7 $-4 $-1 $2 $5 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-7.13$-4.42$-1.10----
Avg Forecast$-7.79$-4.36$-0.80$-0.47$-0.08$0.53$0.66
High Forecast$-5.64$-4.14$-0.79$-0.13$0.05$0.68$0.85
Low Forecast$-9.72$-4.59$-0.81$-0.81$-0.32$0.36$0.44
Surprise %-8.47%1.38%37.50%----

Revenue Forecast

$35M $51M $67M $83M $99M $115M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$91.50M$100.39M$37.86M----
Avg Forecast$49.84M$105.36M$49.66M$68.06M$87.88M$80.97M$84.52M
High Forecast$59.33M$114.07M$53.09M$76.94M$89.82M$98.63M$102.96M
Low Forecast$39.25M$98.57M$44.51M$54.17M$85.94M$60.67M$63.33M
Surprise %83.56%-4.72%-23.76%----

Net Income Forecast

$-500M $-390M $-280M $-170M $-60M $50M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-254.14M$-217.57M$-57.25M----
Avg Forecast$-383.79M$-217.57M$-39.47M$-27.87M$-6.58M$28.36M$32.52M
High Forecast$-277.76M$-204.02M$-39.05M$-6.27M$2.39M$33.52M$41.75M
Low Forecast$-478.73M$-226.15M$-39.89M$-39.72M$-15.55M$17.61M$21.92M
Surprise %-33.78%-45.04%----

TSVT Forecast FAQ

Is 2seventy bio stock a buy?

2seventy bio stock has a consensus rating of Hold, based on 9 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 5 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that 2seventy bio is a neutral investment for most analysts.

What is 2seventy bio's price target?

2seventy bio's price target, set by 9 Wall Street analysts, averages $5 over the next 12 months. The price target range spans from $5 at the low end to $5 at the high end, suggesting a potential 0.40% change from the previous closing price of $4.98.

How does 2seventy bio stock forecast compare to its benchmarks?

2seventy bio's stock forecast shows a 0.40% upside, underperforming the average forecast for the healthcare stocks sector (35.25%) and underperforming the biotech stocks industry (86.56%).

What is the breakdown of analyst ratings for 2seventy bio over the past three months?

  • April 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 0% Strong Buy, 25.00% Buy, 50.00% Hold, 0% Sell, 25.00% Strong Sell.
  • February 2025: 0% Strong Buy, 40.00% Buy, 40.00% Hold, 0% Sell, 20.00% Strong Sell.

What is 2seventy bio’s EPS forecast?

2seventy bio's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.47, marking a -57.27% decrease from the reported $-1.1 in 2024. Estimates for the following years are $-0.08 in 2026, $0.53 in 2027, and $0.66 in 2028.

What is 2seventy bio’s revenue forecast?

2seventy bio's average annual revenue forecast for its fiscal year ending in December 2025 is $68.06M, reflecting a 79.77% increase from the reported $37.86M in 2024. The forecast for 2026 is $87.88M, followed by $80.97M for 2027, and $84.52M for 2028.

What is 2seventy bio’s net income forecast?

2seventy bio's net income forecast for the fiscal year ending in December 2025 stands at $-27.868M, representing a -51.32% decrease from the reported $-57.247M in 2024. Projections indicate $-6.581M in 2026, $28.36M in 2027, and $32.52M in 2028.